Fig. 5From: Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITTAvailable anti-FXa activity (U/mL) levels through the danaparoid treatment course. Time points: 1 = on admission day, 2 = at 1–3 days, 3 = 4–7 days, 4 = 8–14 days, 5 = 15–30 daysBack to article page